A new study looked at the effectiveness of the Trump administration's proposal to require drugmakers to state prices in TV commercials. While putting the costs in did affect consumers, the impact was muted if the ad's language suggests that some people could get the treatment for free. In other pharmaceutical news: foreign drug pricing, the controversial 340B program, negotiating powers for Medicaid, and more.

from Kaiser Health News http://bit.ly/2AYhari

0 comments:

Post a Comment

Popular Posts